Stay updated on CPX-351 and Ivosidenib in IDH1 AML Clinical Trial
Sign up to get notified when there's something new on the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page.

Latest updates to the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision: v3.3.3 was added; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedA new version entry on 2025-11-21 adds a 'Study Status' section with revision v3.3.2, and the prior revision v3.2.0 was removed on 2025-06-12.SummaryDifference0.4%

- Check48 days agoChange DetectedThe page history shows the removal of a government funding notice that warned about potential delays and downtime. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check62 days agoChange DetectedNo substantive changes to the study status, eligibility, or record history are evident between the old and new screenshots. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check91 days agoChange Detected- Added a government funding notice about possible delays and status, and updated operating details for the NIH Clinical Center; - Updated version to v3.2.0; - Removed the previous version label v3.1.0.SummaryDifference12%

- Check98 days agoChange DetectedUpgrade applied: version updated from v3.0.2 to v3.1.0.SummaryDifference0.3%

Stay in the know with updates to CPX-351 and Ivosidenib in IDH1 AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CPX-351 and Ivosidenib in IDH1 AML Clinical Trial page.